Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4- Therapeutics Pipeline for Treating Cancer and Chronic Diseases

• V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders...

OSS, the Netherlands, 13-02-2024 — Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat...

20230829_Citryll_New CEO_and_New CBO_FINAL

Sirius Pintuition® – Moving from Localization to Surgical Marker Navigation Eindhoven, Netherlands – 28 March 2023 – Sirius...

Curie Capital start nieuw seedfonds.docx

Cleara_PressRelease_Sep222022